logo-full arrow-left arrow-right magnify story members projects twitter facebook youtube download

New Research Priorities from the US National Institutes of Health (NIH) Restricts Prevention Options By Marc-André LeBlanc, Founding member of IRMA

International Rectal Microbicide Advocates (IRMA) and our many partners and allies believe we need an array of HIV prevention options. There has been enormous progress in the field of HIV prevention research in recent years. The remarkably high efficacy of antiretroviral drugs (ARVs) for prevention has been demonstrated, both for oral pre-exposure prophylaxis ( PrEP, now approved and subsidized in several countries ) and through treatment leading to viral suppression or “undetectability” ( U=U, Undetectable = Untransmittable ).

Microbicide—products that could be used vaginally or rectally to reduce a … Read more 


 


 


 

This blog first appeared in the Huffington Post Canada here .

By Dr. Zeda F. Rosenberg

As we consider how to reach the end of HIV/AIDS, we must recognize that doing so will require giving women new ways to protect themselves against the virus.

Women are especially vulnerable to HIV because a combination of biology and gender inequities renders them more susceptible to infection than men. In sub-Saharan Africa, HIV is as at least two times more prevalent in young women ages 15 to 24 than in young men, partly because women lack effective and discreet tools they can use on their own to protect themselves. … Read more